|
2007E-0011:
Patent Extension Application for Lantus (insulin glargine rDNA origin),
U.S. Patent No. 5,101,013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| APP1
|
| 01/05/2007
|
| 01/05/2007
|
| Private Industry
|
| Hoechst AG
|
|
|
|
|
|
|
| Table
of Contents
|
|
|
|
|
| Signature:
|
| Stephen L. Nesbitt
|
|
|
|
|
| LET1
|
| 01/05/2007
|
| 01/05/2007
|
| Federal Government
|
| U.S. Patent and Trademark
Office to FDA/CDER (HFD-7)
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Mary C. Till
|
|
|
|
|
| LET2
|
| 01/26/2007
|
| 01/26/2007
|
| Federal Government
|
| FDA/CDER to the U.S.
Patent and Trademark Office
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Jane A. Axelrad
|
|
|
|
|
| LET3
|
| 03/07/2007
|
| 03/07/2007
|
| Federal Government
|
| U.S. Patent and Trademark
Office to FDA/CDER (HFD-7)
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Mary C. Till
| |
|
|
|
|
Top
| Up
Page last updated:
April 4, 2007
|
